Skip to main content
Clinical Trials/NCT04603456
NCT04603456CompletedPhase 4

MicroRNA-155 Assay in Childhood Allergic Rhinitis Before and After Combined Sublingual Immunotherapy and Probiotics

Zagazig University1 site in 1 country45 target enrollmentStarted: September 1, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
45
Locations
1
Primary Endpoint
Total nasal symptom score between before and after treatment

Study Overview

Brief Summary

The investigators aimed to explore miRNA-155 change in response to sublingual immunotherapy (SLIT), probiotics and combined treatment with SLIT and probiotics in AR children.

Detailed Description

Allergic rhinitis (AR) is an inflammatory state characterized by a disturbance of immunoregulatory mechanisms that leads to an amplified T helper "Th-2" response. Micro-RNAs (miRNAs) are short single-stranded RNA molecules that post transcriptionally control gene expression and can mediate allergic process. The aim of this study was to explore miRNA-155 change in response to sublingual immunotherapy (SLIT), probiotics and combined treatment with SLIT and probiotics in AR children.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
5 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children aged 5-18 years
  • Diagnosed as having AR
  • With positive skin test to grass pollen

Exclusion Criteria

  • Anatomical abnormalities of upper respiratory tract,
  • Previous immunotherapy,
  • Clinically significant inflammatory diseases,
  • Malignancies,
  • Chronic treatment with systemic corticosteroids or immune suppressive drugs

Arms & Interventions

Probiotic Group

Experimental

consisted of 15 cases who received probiotics only. A drug called Lacteol fort (Rameda Company) . A sachet was taken once daily for three months. Each sachet contains 10 billions lactobacilli.

Intervention: Lacteol fort (Drug)

SLIT Group

Experimental

included 15 children who received SLIT for 6 months. Standardized Timothy Grass Pollen (Phleum pratense)

Intervention: Standardized Timothy Grass Pollen (Drug)

Combined treatment Group

Experimental

included 15 children who received probiotics and SLIT. A drug called Lacteol fort was administered A sachet was taken once daily for 3 months . Standardized Timothy Grass Pollen was taken for 6 months

Intervention: Lacteol fort and Standardized Timothy Grass Pollen (Drug)

Outcomes

Primary Outcomes

Total nasal symptom score between before and after treatment

Time Frame: 6 months

Total Nasal Symptom Score was evaluated for the three groups at the start of the study and after 6 months. TNSS is the sum of scores for each of nasal obstruction, sneezing, nasal itching, and rhinorrhea at each time point, by means of a four-point scale (0-3) . TNSS is estimated by addition of the score for each of the symptoms to a total out of 12

Secondary Outcomes

  • Serum miR-155 expression at the start and end of the study(6 months)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Fedaa Nabil

Assisstant lecturer

Zagazig University

Study Sites (1)

Loading locations...

Similar Trials

miRNA-155 Assay Before and After... | Clinical Trial